Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Revision metadata updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T03:54:33.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T13:12:15.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. This appears to be a versioning update to the documentation with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-02-07T07:32:54.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These changes affect only UI text and metadata and do not alter substantive study information, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-01-24T04:55:48.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added. Revision: v3.3.3 removed.
    Difference
    0.0%
    Check dated 2026-01-17T03:35:14.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Locations section was reorganized into a single comprehensive list of participating sites across the US and various countries, consolidating numerous state and country entries. The previous per-location headings (e.g., Alabama Locations) were removed, and the HHS Vulnerability Disclosure link was deleted.
    Difference
    3%
    Check dated 2025-12-19T12:52:49.000Z thumbnail image

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.